The putative role of apoptosis-modified histones for the induction of autoimmunity in Systemic Lupus Erythematosus

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1441-1446

  Gabler, Christoph ^a   Kalden, Joachim R ^a   Lorenz, Hanns Martin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Annexin V; Apoptosis; Autoantibody; AxV; Double stranded DNA; dsDNA; H1, H2A, H2B, H3, H4; Histones 1, 2A, 2B, 3, 4; IL 2; Interleukin 2; Med; Medium; PBMC; Peripheral blood mononuclear cells; PI; Propidium iodide; SLE; Systemic Lupus Erythematosus; Ultraviolet; UV

Indexed keywords

AUTOANTIBODY; DNA; DNA ANTIBODY; DNA FRAGMENT; ETOPOSIDE; HISTONE; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE;

APOPTOSIS; AUTOIMMUNITY; CELL ACTIVATION; CELL DEATH; CELL LYSATE; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG EFFECT; HUMAN; LYMPHOBLAST; NUCLEOSOME; OUTER MEMBRANE; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET IRRADIATION; ANIMAL; BLOOD; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNITY; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NUCLEOSOMES;

EID: 0642314385     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00495-7     Document Type: Conference Paper

References (53)

1. Tan E.M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:1989;93-151.
2. Amoura Z., Piette J.-C., Bach J.-F., Koutouzov S. The key role of nucleosomes in lupus. Arthritis Rheum. 42:1999;833-843.
3. Bell D.A., Morrison B., VandenBygaart P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85:1990;1487-1496.
4. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
5. Arbuckle M.R., James J.A., Kohlhase K.F., Rubertone M.V., Dennis G.J., Harley J.B. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 54:2001;211-219.
6. Davis P., Percy J.S., Russell A.S. Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann. Rheum. Dis. 36:1977;157-159.
7. Lorenz H.M., Herrmann M., Winkler T., Gaipl U., Kalden J.R. Role of apoptosis in autoimmunity. Apoptosis. 5:2000;443-449.
8. Emlen W., Niebur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152:1994;3685-3692.
9. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
10. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
11. Higuchi Y., Matsukawa S. Active oxygen-mediated chromosomal 1-2 Mbp giant DNA fragmentation into internucleosomal DNA fragmentation in apoptosis of glioma cells induced by glutamate. Free Radic. Biol. Med. 24:1998;418-426.
12. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
13. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216.
14. Andree H.A., Reutelingsperger C.P., Hauptmann R., Hemker H.C., Hermens W.T., Willems G.M. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 265:1990;4923-4928.
15. Gaipl U.S., Kuenkele S., Voll R.E., Beyer T.D., Kolowos W., Heyder P., Kalden J.R., Herrmann M. Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ. 8:2001;327-334.
16. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
17. Bacso Z., Everson R.B., Eliason J.F. The DNA of Annexin V-binding apoptotic cells is highly fragmented. Cancer Res. 60:2000;4623-4628.
18. Gabler C., Schiller M., Blank N., Kriegel M., Winkler S., Berden J.H., Kalden J.R., Lorenz H.M. Contents of core histones in the cytoplasm of human lymphoblasts correlates with features of early apoptosis. Clin. Exp. Rheumatol. 20:2002;262.
19. Gabler C., Schiller M., Blank N., Kriegel M., Winkler S., Berden J.H., Kalden J.R., Lorenz H.M. Different contents of each histone in the cytoplasm of human lymphoblasts after induced apoptosis. Ann. Rheum. Dis. 61(Suppl. 1):2002;36.
20. Gabler C, Blank N, Winkler S, Kalden JR, Lorenz HM. Accumulation of histones in the cytoplasm precedes expression of apoptosis-related phagocytosis signals in human lymphoblasts. In: Proceedings of the Meeting Apoptosis 2003 in Luxembourg. p. 58.
21. Huggins M.L., Todd I., Cavers M.A., Pavuluri S.R., Tighe P.J., Powell R.J. Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin. Exp. Immunol. 118:1999;322-328.
22. Salgame P., Varadhachary A.S., Primiano L.L., Fincke J.E., Muller S., Monestier M. An ELISA for detection of apoptosis. Nucleic Acids Res. 25:1997;680-681.
23. Eckert A., Oster M., Zerfass R., Hennerici M., Müller W.E. Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12:2001;98-105.
24. Lecoeur H. Nuclear apoptosis detection by flow cytometry: influence of endogenous endonucleases. Exp. Cell Res. 277:2002;1-14.
25. Fournel S., Genestier L., Rouault J.P., Lizard G., Flacher M., Assossou O., Revillard J.P. Apoptosis without decrease of cell DNA content. FEBS Lett. 367:1995;188-192.
26. Wu D., Ingram A., Lahti J.H., Mazza B., Grenet J., Kapoor A., Liu L., Kidd V.J., Tang D. Apoptotic release of histones from nucleosomes. J. Biol. Chem. 277:2002;12001-12008.
27. Earnshaw W.C. Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7:1995;337-343.
28. van Nieuwenhuijze A.E., van Lopik T., Smeenk R.J., Aarden L.A. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus. Ann. Rheum. Dis. 62:2003;10-14.
29. Gabler C., Blank N., Schiller M., Winkler S., Kriegel M., Kalden J.R., Lorenz H.M. Accumulation of histones in the cytoplasm precedes expression of apoptosis-related phagocytosis signals in human lymphoblasts. Immunobiology. 206:2002;241.
30. Steinman C.R. Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis. Am. J. Med. 67:1979;429-435.
31. Raptis L., Menard H.A. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J. Clin. Invest. 66:1980;1391-1399.
32. McCoubrey-Hoyer A., Okarma T.B., Holman H.R. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am. J. Med. 77:1984;23-34.
33. Rumore P.M., Steinman C.R. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 86:1990;69-74.
34. Amoura Z., Piette J.C., Chabre H., Cacoub P., Papo T., Wechsler B., Bach J.F., Koutouzov S. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 40:1997;2217-2225.
35. Burlingame R.W., Rubin R.L., Balderas R.S., Theofilopoulos A.N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91:1993;1687-1696.
36. Amoura Z., Chabre H., Koutouzov S., Lotton C., Cabrespines A., Bach J.F., Jacob L. Nucleosome-restricted antibodies are detected before anti-dsDNA and/ or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37:1994;1684-1688.
37. Lorenz H.-M., Grünke M., Hieronymus T., Herrmann, Kühnel A., Manger B., Kalden J.R. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum. 40:1997;306-317.
38. Perniok A., Wedekind F., Herrmann M., Specker C., Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 7:1998;113-118.
39. Krapf F., Herrmann M., Leitmann W., Kalden J.R. Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients. Clin. Exp. Immunol. 75:1989;336-342.
40. Casciola-Rosen L., Andrade F., Ulanet D., Wong W.B., Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190:1999;815-826.
41. Rosen A., Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6:1999;6-12.
42. Gabler C., Hieronymus T., Blank N., Schiller M., Berden J.H., Winkler S., Kalden J.R., Lorenz H.M. Histone release into the cytoplasm of human PBMCs and preapoptotic lymphoblasts. Ann. Rheum. Dis. 60(Suppl. 1):2001;63.
43. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41:1998;1241-1250.
44. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L., Kirchner T., Kalden J.R., Herrmann M. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46:2002;191-201.
45. Berden J.H., Licht R., van Bruggen M.C., Tax W.J. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr. Opin. Nephrol. Hypertens. 8:1999;299-306.
46. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1994;1317-1330.
47. Krieg A.M. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J. Clin. Immunol. 15:1995;284-292.
48. Tsai Y.T., Chiang B.L., Kao Y.F., Hsieh K.H. Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. Int. Arch. Allergy Immunol. 106:1995;235-240.
49. Chitrabamrung S., Rubin R.L., Tan E.M. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol. Int. 1:1981;55-60.
50. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25:2000;177-181.
51. Gunnarsson I., Guo-Zhong F., Mannherz H.G., Napirei M., Gültekin A., Frostegard J. Decreased serum Dnase 1 activity levels in SLE patients with active disease. Ann. Rheum. Dis. 60(Suppl. 1):2001;185.
52. Voll R.E., Roth E.A., Girkontaite I., Fehr H., Herrmann M., Lorenz H.-M., Kalden J.R. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 40:1997;2162-2171.
53. Bruns A., Bläss S., Hausdorf G., Burmester G.R., Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 43:2000;2307-2315.